Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Med Sci Monit ; 25: 3090-3099, 2019 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-31026254

RESUMEN

BACKGROUND In the pathogenesis and progression of prostate cancer, cell proliferation and cell migration results in tumor invasion and metastasis that is associated with patient morbidity and mortality. Rho-associated protein kinase (ROCK) has previously been shown to be upregulated in prostate cancer, but its biological role remains poorly understood. This study aimed to investigate the role of ROCK in the proliferation and migration of PC-3 and DU145 prostate cancer cells and to identify the possible targets involved by knockdown of ROCK1 and ROCK2 RNA expression. MATERIAL AND METHODS An RNA interference (RNAi) assay was performed to silence the expression of ROCK1 and ROCK2 in the PC-3 and DU145 human prostate cancer cell lines. Cells were also treated with a specific ROCK inhibitor, Y27632. A cell counting kit-8 (CCK-8) assay was used to determine the proliferation rate of prostate cancer cells, and cell migration and invasion assays were performed. Western blot and polymerase chain reaction were used to measure protein and RNA expression levels. RESULTS In PC-3 and DU145 prostate cancer cells, knockdown of ROCK1 and ROCK2 reduced cell migration and invasion. ROCK1 and ROCK2 regulated cell proliferation in PC-3 and DU145 prostate cancer cells. Protein levels of phosphorylated LIM kinase 1 (p-LIMK1) and matrix metalloproteinase-2 (MMP-2) were reduced in ROCK1 and ROCK2 siRNA transfected cells. CONCLUSIONS In PC-3 and DU145 human prostate cancer cells, ROCK promoted cell proliferation and migration by targeting LIMK1 and MMP-2.


Asunto(s)
Quinasas Lim/metabolismo , Metaloproteinasa 2 de la Matriz/metabolismo , Neoplasias de la Próstata/enzimología , Quinasas Asociadas a rho/metabolismo , Adenocarcinoma/enzimología , Adenocarcinoma/patología , Animales , Línea Celular Tumoral , Movimiento Celular/fisiología , Proliferación Celular/fisiología , Técnicas de Silenciamiento del Gen , Humanos , Neoplasias Pulmonares/enzimología , Neoplasias Pulmonares/secundario , Masculino , Ratones , Ratones Desnudos , Células PC-3 , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , ARN Interferente Pequeño/administración & dosificación , ARN Interferente Pequeño/genética , Transducción de Señal , Quinasas Asociadas a rho/genética
2.
Biochem Biophys Res Commun ; 476(4): 319-325, 2016 08 05.
Artículo en Inglés | MEDLINE | ID: mdl-27233612

RESUMEN

The multidrug and toxic compound extrusion (MATE) transporters mediate the coupled exchange of organic substrates and monovalent cations have been recently implicated in various plant biological activities. In this work, we isolated a dominant mutant from an Arabidopsis activation-tagging mutant pool. This mutant exhibits pleiotropic phenotype including early flowering, dwarf and bushy architecture, minified lateral organs and early leaf senescence, and is therefore designated early leaf senescence 1-Dominaint (els1-D). Genotyping assays showed that els1-D is a gain-of-function mutant of a novel MATE transporter gene, ELS1, which encodes a close homolog of the previously reported ADP1, BCD1 and DTX50. Further investigations revealed that the overexpression of ELS1 reduces iron content in els1-D, and the accelerated senescence of the detached els1-D leaves can be recovered by exogenous iron supply. In addition, we also found that ELS1 is an iron responsive gene. Based on these findings, we proposed that ELS1 is related to leaf senescence and iron homeostasis in Arabidopsis.


Asunto(s)
Proteínas de Arabidopsis/metabolismo , Arabidopsis/fisiología , Hierro/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Hojas de la Planta/fisiología , Envejecimiento/fisiología , Proteínas de Arabidopsis/genética , Homeostasis/fisiología , Proteínas de Transporte de Membrana/genética , Mutación , Proteínas de Transporte de Catión Orgánico/genética , Hojas de la Planta/genética , Plantas Modificadas Genéticamente
3.
Plant Cell Rep ; 35(3): 629-40, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26650834

RESUMEN

KEY MESSAGE: We identified 23 novel proteins that can interact with At TRN1. These proteins are potential candidates of At TRN1 cargo proteins, which will facilitate our comprehending of At TRN1 functions in Arabidopsis. Tranportin 1 (TRN1) carries out the nucleo-cytoplasmic transport of many proteins, thereby ensuring that each of them is delivered to the right compartment for its proper function. These cargo proteins involved in lots of important processes, such as alternative pre-mRNA splicing, transcriptional regulation, and protein translation. Current understanding of cargo proteins transported by Arabidopsis thaliana transportin 1 (AtTRN1) is limited. Here, first we employed the yeast two-hybrid (Y2H) screening to identify proteins that can interact with AtTRN1 in Arabidopsis, and 12 novel proteins were found. Searching for PY-NLS motif in these 12 proteins suggested that no typical PY-NLS motif was present. We next investigated the specific motifs that will mediate the interactions in these sequences, and found that thirteen truncated fragments interacted with AtTRN1, containing 8 acidic and 5 basic fragments, respectively. We also searched the Arabidopsis proteome for homologs of cargo proteins of yeast Kapl04p and mammalian Kapß2, and PY-NLS motif-containing proteins. Among these proteins, 11 were identified to interact with AtTRN1. The interactions between all the 23 proteins and AtTRN1 were confirmed by both Y2H and bimolecular fluorescence complementation (BiFC) assays. Our results show that AtTRN1 recognizes a broad spectrum of proteins having diverse functions, which will potentially be the cargoes of AtTRN1. Taken together, these results demonstrate the feasibility and potential power of these methods to identify cargo proteins of AtTRN1, and represent a primary and significant step in interpretation of AtTRN1 functionalities.


Asunto(s)
Proteínas de Arabidopsis/metabolismo , Arabidopsis/metabolismo , Proteoma/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Técnicas del Sistema de Dos Híbridos , Transporte Activo de Núcleo Celular , Secuencias de Aminoácidos/genética , Secuencia de Aminoácidos , Arabidopsis/genética , Proteínas de Arabidopsis/genética , Estudios de Factibilidad , Unión Proteica , Mapeo de Interacción de Proteínas/métodos , Transporte de Proteínas , Proteoma/genética , Receptores Citoplasmáticos y Nucleares/genética , Reproducibilidad de los Resultados
4.
AAPS PharmSciTech ; 17(6): 1376-1382, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26753818

RESUMEN

A critical issue for alcohol-induced liver disease (ALD) therapeutics is the lack of a highly efficient delivery system. In this study, a Puerarin-propylene glycol-liposome system was prepared for the purpose of targeting puerarin, an isoflavon, to the liver. Transmission electron microscope (TEM) results showed the liposomes to be spherical in shape with an average diameter of 182 nm with a polydispersity index of 0.239. The zeta potential of the particles was about -30 mV. The entrapment efficiency of puerarin was above 90%. MTT-based assay in HpeG2 cells showed no significant cytotoxicity in the presence of up to 25% concentration of the system containing 3% puerarin. In vivo performance of this system was studied in mice. Pharmacokinetics and distribution of puerarin-PG-liposome system was studied relative to puerarin solution at the same dose levels. The results show that puerarin-PG-liposome prolonged drug retention time and decreased elimination of puerarin in mice (AUC of liposome system and solution was 9.5 and 4.0 mg h L-1, respectively). Furthermore, propylene glycol (PG)-liposome system enhanced puerarin distribution into liver and spleen, while decreasing puerarin distribution in other tissues. Overall, the puerarin-PG-liposome system showed enhanced therapeutic effect in mice with ALD.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Isoflavonas/química , Isoflavonas/farmacología , Liposomas/química , Hígado/efectos de los fármacos , Propilenglicol/química , Animales , Línea Celular Tumoral , Sistemas de Liberación de Medicamentos/métodos , Etanol/efectos adversos , Células Hep G2 , Humanos , Isoflavonas/farmacocinética , Hígado/metabolismo , Ratones , Tamaño de la Partícula , Bazo/metabolismo , Distribución Tisular
5.
Expert Rev Clin Pharmacol ; 17(1): 101-110, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-38069611

RESUMEN

OBJECTIVE: This study aimed to explore a comprehensive empirical investigation and assess SCARs related to valaciclovir or acyclovir based on FAERS database from FDA, thus providing a theoretical foundation for the rational application of drugs in clinic. METHODS: SCARs reports relevant to valaciclovir or acyclovir were searched in FAERS database from the 2004 Q1 to 2023 Q2. These data were further mined by a proportional analysis and Bayesian approach to detect signals of SCARs caused by two drugs. Meanwhile, the clinical characteristics, onset time, correlation, and stratification analysis of the two drugs in SCARs were analyzed. RESULTS: Both drugs exhibited positive signals for drug reaction with DRESS, AGEP, TEN, SJS-TEN overlap and SJS. The median onset time of SCARs caused by valaciclovir or acyclovir was 30 days vs 10 day for DRESS, 11 days vs 9 days for AGEP, 17 days vs 12 days (TEN) and 12 days vs 8 days (SJS). Excluding the effect of combinational drugs, there was an association between the two antiviral drugs and SCARs. CONCLUSION: By analyzing the FAERS database, the risk trends of SCARs caused by valaciclovir or acyclovir have been identified, providing valuable insights to recognize various types of SCARs in clinics.


Asunto(s)
Aciclovir , Cicatriz , Humanos , Aciclovir/efectos adversos , Valaciclovir/efectos adversos , Cicatriz/inducido químicamente , Teorema de Bayes , Valina/efectos adversos , Antivirales/efectos adversos
6.
Sci Total Environ ; 923: 171609, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38461994

RESUMEN

Exposure to carbazole (CZ) and polyhalogenated carbazoles (PHCZs) may pose a threat to human health, owing to their potential dioxin-like toxicity. Until now, the presence of these chemicals in the human urine from the general population is still unclear. Human urine samples (n = 210) were taken from the general population in Quzhou, China in this study, and were analyzed for CZ and 14 PHCZs. CZ and nine PHCZs were detected in collected human urine. CZ (detection frequency 100 %), 3-chlorocarbazole (3-CCZ; 88 %), 3,6-dichlorocarbzole (36-CCZ; 84 %), and 3-bromocarbazole (3-BCZ; 80 %) were more frequently detected. Among detected PHCZs, 3-CCZ (mean 0.49 ng/mL, < LOD-4.3 ng/mL) had comparatively higher urinary levels, followed by 3-BCZ (0.30 ng/L, < LOD-1.9 ng/mL) and 36-CCZ (0.20 ng/L, < LOD-1.4 ng/mL). Urinary concentrations of CZ in male participants (1.3 ± 0.26 ng/mL) were significantly (p < 0.05) higher than that in female participants (0.92 ± 0.24 ng/mL). No obvious trend in urinary concentrations with the age of participants was found for CZ and detected PHCZs. The mean daily excretion was found highest for CZ (31 ng/kg bw/day), followed by 3-CCZ (19 ng/kg bw/day) and 3-BCZ (8.5 ng/kg bw/day). This study provides the first data, to our knowledge, on the presence and levels of CZ and PHCZs in human urine, which is necessary for conducting the human exposure risk assessment.


Asunto(s)
Dioxinas , Dibenzodioxinas Policloradas , Humanos , Femenino , Masculino , Carbazoles/toxicidad , China
7.
Eur J Pharm Sci ; 187: 106468, 2023 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-37220818

RESUMEN

Owing to the difficult-to-penetrate blood-brain barrier (BBB), glioblastoma (GBM) doesn't respond well to the current chemical therapeutics. In this study, ultra-small micelles (NMs) self-assembled by RRR-a-tocopheryl succinate-grafted-ε-polylysine conjugate (VES-g-ε-PLL) as the delivery vehicle of chemical therapeutics in conjunction with ultrasound-targeted microbubble destruction (UTMD) to surmount BBB and treat GBM. Docetaxel (DTX) as a hydrophobic model drug was incorporated into NMs. DTX-loaded micelles (DTX-NMs) with 3.08% of drug loading exhibited a hydrodynamic diameter (33.2 nm) and positive Zeta potential (16.9 mV), having a remarkable tumor-permeating capacity. Furthermore, DTX-NMs presented good stability in physiologic condition. The sustained- release profile of DTX-NMs was also displayed by dynamic dialysis. Treatment of DTX-NMs together with UTMD led to more pronounced apoptosis of C6 tumor cells than DTX-NMs alone. Moreover, compared with the DTX solution or DTX-NMs alone, the combination of DTX-NMs with UTMD had a stronger inhibitory effect on tumor growth for GBM-bearing rats. The median survival period of GBM-bearing rats was extended to 75 days in the DTX-NMs+UTMD group from under 25 days in the control group. The invasive growth of glioblastoma was largely inhibited by the combination of DTX-NMs with UTMD, which was demonstrated by staining of Ki67, caspase-3, and CD31, together with TUNEL assay. In conclusion, the combination of ultra-small micelles (NMs) with UTMD may be a promising strategy to overcome the limitations of the first-line chemotherapeutics against GBM.


Asunto(s)
Antineoplásicos , Glioblastoma , Ratas , Animales , Docetaxel/farmacología , Micelas , Glioblastoma/tratamiento farmacológico , Glioblastoma/patología , Microburbujas , Apoptosis , Antineoplásicos/química , Línea Celular Tumoral
8.
Front Cardiovasc Med ; 10: 1100006, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37351285

RESUMEN

Background: Danlou tablets exert auxiliary advantages in treating coronary heart disease (CHD), but a summary of evidence-based proof is lacking. This study aims to systematically evaluate Danlou tablets in treating CHD from two aspects, including efficacy and safety. Methods: By a thorough retrieval of the four English databases, namely, PubMed, The Cochrane Library, Embase, and Web of Science, and the four Chinese databases, namely, CNKI, Wanfang, VIP database, and China Biomedical Literature Service System, we found all randomized controlled trials (RCTs) related to Danlou tablets in treating CHD. The retrieval time was from the construction of the database to April 2022. We engaged two researchers to screen the studies, extract the required data, and assess the risk of bias. We then used RevMan5.3 and STATA.14 software to conduct a meta-analysis. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was used to evaluate the quality of outcome indicators. Results: Seventeen RCTs involving 1,588 patients were included. The meta-analysis results are displayed as follows: clinical treatment effect [risk ratio (RR) = 1.22, 95% confidence interval (CI): 1.16, 1.28, P < 0.00001], angina pectoris duration [MD = -0.2.15, 95% CI: -2.91, -1.04, P < 0.00001], angina pectoris frequency [standard mean difference (SMD) = -2.48, 95% CI: -3.42, -1.54, P < 0.00001], angina pectoris degree [SMD = -0.96, 95% CI: -1.39, -0.53, P < 0.0001], TC [MD = -0.71, 95% CI: -0.92, -0.51, P < 0.00001], TG [MD = -0.38, 95% CI: -0.53, -0.22, P < 0.00001], low-density lipoprotein cholesterol [MD = -0.64, 95% CI: -0.76, -0.51, P < 0.00001], high-density lipoprotein cholesterol [MD = 0.16, 95% CI: 0.11, 0.21, P < 0.00001], and adverse events [RR = 0.46, 95% CI: 0.24, 0.88, P = 0.02]. Conclusion: The current evidence suggests that the combination of Danlou tablets and Western medicine can enhance the efficacy of CHD and does not increase adverse events. However, because of the limited number and quality of the included studies, the results of our study should be treated with caution. Further large-scale RCTs are necessary to verify the benefits of this approach.

9.
Environ Sci Pollut Res Int ; 30(24): 66186-66194, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37097579

RESUMEN

Parabens are a family of endocrine-disrupting chemicals. Environmental estrogens may play a vital role in the development of lung cancer. To date, the association between parabens and lung cancer is unknown. Based on the 189 cases and 198 controls recruited between 2018 and 2021 in Quzhou, China, we measured 5 urinary parabens concentrations and examined the association between urinary concentrations of parabens and lung cancer risk. Cases showed significantly higher median concentrations of methyl-paraben (MeP) (2.1 versus 1.8 ng/mL), ethyl-paraben (0.98 versus 0.66 ng/mL), propyl-paraben (PrP) (2.2 versus 1.4 ng/mL), and butyl-paraben (0.33 versus 0.16 ng/mL) than controls. The detection rates of benzyl-paraben were only 8 and 6% in the control and case groups, respectively. Therefore, the compound was not considered in the further analysis. The significant correlation between urinary concentrations of PrP and the risk of lung cancer (odds ratio (OR)adjusted = 2.22, 95% confidence interval (CI): 1.76, 2.75; Ptrend < 0.001) was identified in the adjusted model. In the stratification analysis, we found that urinary concentrations of MeP were significantly associated with lung cancer risk (OR = 1.16, 95% CI: 1.01, 1.27 for the highest quartile group). Besides, comparing the second, third, and fourth quartile groups with the lowest group of PrP, we also observed urinary PrP concentrations associated with lung cancer risk, with the adjusted OR of 1.52 (95% CI: 1.29, 1.65, Ptrend = 0.007), 1.39 (95% CI: 1.15, 1.60, Ptrend = 0.010), and 1.85 (95% CI: 1.53, 2.30, Ptrend = 0.001), respectively. MeP and PrP exposure, reflected in urinary concentrations of parabens, may be positively associated with the risk of lung cancer in adults.


Asunto(s)
Contaminantes Ambientales , Neoplasias Pulmonares , Adulto , Humanos , Parabenos/análisis , Contaminantes Ambientales/análisis , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/epidemiología , Exposición a Riesgos Ambientales/análisis
10.
Tree Physiol ; 43(7): 1233-1249, 2023 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-37017317

RESUMEN

Long noncoding ribonucleic acids (lncRNAs) play crucial roles in regulating key biological processes; however, our knowledge of lncRNAs' roles in plant adaptive evolution is still limited. Here, we determined the divergence of conserved lncRNAs in closely related poplar species that were either tolerant or sensitive to salt stress by comparative transcriptome analysis. Among the 34,363 identified lncRNAs, ~3% were shared among poplar species with conserved sequences but diversified in their function, copy number, originating genomic region and expression patterns. Further cluster analysis revealed that the conserved lncRNAs showed more similar expression patterns within salt-tolerant poplars (Populus euphratica and P. pruinosa) than between salt-tolerant and salt-sensitive poplars. Among these lncRNAs, the antisense lncRNA lncERF024 was induced by salt and the differentiated expression between salt-sensitive and salt-tolerant poplars. The overexpression of lncERF024 in P. alba var. pyramidalis enhanced poplar tolerance to salt stress. Furthermore, RNA pull-down and RNA-seq analysis showed that numerous candidate genes or proteins associated with stress response and photosynthesis might be involved in salt resistance in PeulncERF024-OE poplars. Altogether, our study provided a novel insight into how the diversification of lncRNA expression contributes to plant adaptation traits and showed that lncERF024 may be involved in the regulation of both gene expression and protein function conferring salt tolerance in Populus.


Asunto(s)
Populus , ARN Largo no Codificante , Transcriptoma , ARN Largo no Codificante/genética , Populus/genética , Perfilación de la Expresión Génica , Estrés Salino/genética , Regulación de la Expresión Génica de las Plantas , Estrés Fisiológico/genética
11.
J Colloid Interface Sci ; 624: 1-13, 2022 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-35660878

RESUMEN

Cellulose acetate membrane (CAM) has become one of the most widely used membrane materials by virtue of stability and hydrophilicity. In this work, to achieve the aim of selective recognition and separation of drug molecule shikimic acid (SA), an effective recognition tactics was proposed by combining boron affinity technology with surface imprinting strategy based on cellulose acetate membrane with low price and biocompatibility. The supporting CAM material was prepared through the phase inversion technique by continuous adjustment of different factors including solvent type and kinds of pore-forming agents, and the optimal CAM with multistage structure and highly porosity was applied for the imprinting of SA. Then the imprinted polymer membrane (MIPs-CAM) was developed via boron affinity surface imprinting polymerization. Various methods (FT-IR, UV-vis, SEM, XPS, AFM and TGA) were used to characterize the structure, morphology, elemental composition, surface roughness and thermal property of the obtained membrane. The as-prepared MIPs-CAM showed homogeneous and abundant imprinted layer, good thermal stability. The batch adsorption results showed that the MIPs-CAM had fast adsorption kinetics, specific recognition ability, and the adsorption capacity could obtain 63.598 mg g-1, which was two times higher than that of non-imprinted membrane (NIPs-CAM). The adsorption isotherms conformed to the Langmuir isotherm and the adsorption processes were spontaneous and endothermic. Additionally, the adsorption capacity of MIPs-CAM still reached 85% of the initial result after five cycles. The experimental results revealed that the molecularly imprinted membrane possessed the advantages of high selectivity and easy recovery compared with the traditional molecular imprinted polymers for SA separation. These results indicate that boron affinity MIPs-CAM with high performance will provide a promising platform for the separation and purification of other cis-diol drug molecules from environmental resources.


Asunto(s)
Impresión Molecular , Polímeros , Adsorción , Boro , Impresión Molecular/métodos , Polimerizacion , Polímeros/química , Espectroscopía Infrarroja por Transformada de Fourier
12.
Front Public Health ; 10: 969070, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36051999

RESUMEN

Objective: We performed a pan-cancer analysis to explore the potential mechanisms of FAT4 in 33 different tumors. Methods: In this study, we selected 33 types of cancers based on the datasets of TCGA (the cancer genome atlas). We analyzed the expression of FAT4 in tumor and normal tissues. Meanwhile, we analyzed the expression levels of FAT4 in tissues from tumors of different stages. Kaplan-Meier survival analysis, Tumor Mutational Burden (TMB), Microsatellite Instability (MSI), immune infiltration analysis, Gene set enrichment analysis (GSEA), and FAT4-related gene enrichment analysis were performed. Results: FAT4 expression in most tumor tissues was lower than in corresponding control tissues. FAT4 expression was different in different stages of bladder cancer (BLCA), kidney clear cell carcinoma (KIRC), and breast cancer (BRCA). In addition, the expression level of FAT4 in different types of tumors has an important impact on the prognosis of patients. FAT4 might influence the efficacy of immunotherapy via tumor burden and microsatellite instability. We observed a statistically positive correlation between cancer-associated fibroblasts and FAT4 expression in most tumors. GSEA of BLCA indicated that low FAT4 expression groups were mainly enriched in calcium signaling pathway and chemokine signaling pathway. GSEA analysis of KIRC suggested low FAT4 expression groups were mainly involved in olfactory transduction and oxidative phosphorylation. Kyoto Encyclopedia of Genes and Genomes (KEGG) indicated that the role of FAT4 in the pathogenesis of cancer may be related to human papillomavirus infection, Hippo signaling pathway, PI3K-Akt signaling pathway, etc. Gene Ontology (GO) enrichment analysis further showed that most of these genes were related to the pathways or cell biology, such as peptidyl-tyrosine phosphorylation, cell junction assembly, protein tyrosine kinase activity, etc. Conclusion: Our study summarized and analyzed the antitumor effect of FAT4 in different tumors comprehensively, which aided in understanding the role of FAT4 in tumorigenesis from the perspective of clinical tumor samples. Pan-cancer analysis showed that FAT4 to be novel biomarkers for various cancers prognosis.


Asunto(s)
Cadherinas/metabolismo , Neoplasias , Fosfatidilinositol 3-Quinasas , Proteínas Supresoras de Tumor/metabolismo , Cadherinas/genética , Línea Celular Tumoral , Humanos , Inestabilidad de Microsatélites , Neoplasias/genética , Fosfatidilinositol 3-Quinasas/genética , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Supresoras de Tumor/genética
13.
Medicine (Baltimore) ; 99(39): e22357, 2020 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-32991451

RESUMEN

BACKGROUND: The incidence and mortality of colorectal cancer are high. Chemotherapy is currently the commonly used therapeutic scheme, but there are drug resistance and toxic and side effects. Kanglaite (KLT) injection is a broad-spectrum anticancer drug extracted from Semen Coicis (Yi Yi Ren), which has been widely used in the treatment of colorectal cancer. Clinical practice shows that KLT injection combined with chemotherapy has certain therapeutic advantages, but there is a lacking of evidence of evidence-based medicine. The purpose of this study is to systematically investigate the efficacy and safety of KLT injection combined with chemotherapy in the treatment of colorectal cancer. METHODS: Randomized controlled trials of KLT injection combined with chemotherapy in the treatment of colorectal cancer were retrieved from English databases (PubMed, Embase, Web of Science, the Cochrane Library) and Chinese databases (China National Knowledge Infrastructure, Wanfang, Chongqing VIP Chinese Science and Technology Periodical Database, Chinese Biological and Medical database), as well as searching Baidu academic and Google academic manually, and the retrieval time was from their establishment to August 2020. Two researchers independently conducted data extraction and literature quality evaluation on the quality of the included literatures, and meta-analysis was conducted on the included literatures using RevMan 5.3 (developed by the UK's International Cochrane Collaboration). RESULTS: This study assessed the efficacy and safety of KLT injection combined with chemotherapy in the treatment of colorectal cancer by effective rate, Karnofsky Performance Status, Carcinoemybryonic Angtigen remission rate, pain remission rate, and incidence of adverse reactions etc. CONCLUSIONS:: This study will provide reliable evidence-based evidence for the clinical application of KLT injection combined with chemotherapy in the treatment of colorectal cancer. ETHICS AND DISSEMINATION: The private information from individuals will not be published. This systematic review also will not involve endangering participant rights. Ethical approval is not required. The results may be published in a peer-reviewed journal or disseminated in relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/EKVAF.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias Colorrectales/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Factores de Edad , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Dolor en Cáncer/tratamiento farmacológico , Antígeno Carcinoembrionario/sangre , Neoplasias Colorrectales/patología , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/efectos adversos , Humanos , Estado de Ejecución de Karnofsky , Ensayos Clínicos Controlados Aleatorios como Asunto , Proyectos de Investigación , Metaanálisis como Asunto
14.
Colloids Surf B Biointerfaces ; 191: 111025, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32305624

RESUMEN

Biocatalytic removal with laccase immobilized on diverse membranes offers an attractive option to search alternative to traditional wastewater treatment processes for the removal of high toxic azo dye. In this work, the modified poly(vinylidene fluoride) membrane (PVDF) with chemical stability and high mechanical strength was developed for laccase immobilization via covalent bonding. The key design for the synthesis of biocatalytic membrane is the construction of hybrid bio-inorganic structure on the surface of polydopamine (PDA)-coated PVDF (PDA@PVDF). In this respect, the PDA layer was used as a secondary platform for the grafting of 3-triethoxysilylpropylamine (APTES) modified Fe2O3@SiO2 cubes (FS@cubes) via a solvothermal process, resulting in the formation of FS@cubes-PDA@PVDF membrane. Subsequently, laccase was immobilized on the surface of FS@ cubes-PDA@PVDF via gluteraldehyde (GA) crosslinking (Lac-FS@ cubes-PDA@PVDF). The removal efficiency of congo red by Lac-FS@cubes-PDA @PVDF reached 97.1 % under optimal reaction conditions (pH 7.0 and temperature 35 ℃), which was more efficient than free laccase. Moreover, the as-prepared Lac-FS@cubes-PDA@PVDF not only exhibited an excellent stability after low temperature storage, but also showed an outstanding reusability. Therefore, we believe that this work opens up a potential strategy for removal of other water pollutants, and provide a simple and convenient way for large-scale applications of enzyme-catalysis.


Asunto(s)
Colorantes/aislamiento & purificación , Rojo Congo/aislamiento & purificación , Lacasa/química , Polivinilos/química , Contaminantes Químicos del Agua/aislamiento & purificación , Biocatálisis , Colorantes/química , Rojo Congo/química , Enzimas Inmovilizadas/química , Enzimas Inmovilizadas/metabolismo , Lacasa/metabolismo , Tamaño de la Partícula , Polivinilos/metabolismo , Porosidad , Propiedades de Superficie , Contaminantes Químicos del Agua/química
15.
Can J Urol ; 16(1): 4472-7, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19222885

RESUMEN

OBJECTIVE: To compare the detection and management of prostate cancer in one French and six Chinese urological institutions. PATIENTS AND METHODS: All the patients subjected to prostate biopsy for suspected prostate cancer in six Chinese urological institutions and in the department of urology of the Cochin hospital, France, between January 2003 and December 2005 were included. The characteristics of patients and tumors, and the management of prostate cancer were then analyzed. RESULTS: In the Chinese institutions, 95.8% of patients undergoing prostate biopsy presented with urinary disorders. The rate of abnormal digital rectal examination (DRE) ranged from 29.2% to 45.1%. In the French institution, 72.7% of prostate biopsies were performed as a result of prostate cancer screening, and the rate of abnormal DRE was 16.8%. In the Chinese institutions, a total of 979 patients underwent prostate biopsy, with median PSA values varying between 10.2 ng/ml and 33 ng/ml among the institutions. Overall, 408 cases of prostate cancer were diagnosed, with median PSA values varying between 24.3 ng/dl and 174.9 ng/dl and 19.4% of tumors were clinically localized. In the French institution, 565 patients underwent prostate biopsy, with a median PSA value of 7.4 ng/ml and 251 cases of prostate cancer were diagnosed, with a median PSA value of 8.1 ng/ml and 80.9% of tumors were clinically localized. In the Chinese institutions, the majority of patients received surgical or medical castration. The rate of patients subjected to surgical castration varied between 24.2% and 100%. Radical prostatectomy (RP) was performed in only three Chinese hospitals, in which the percentage of patients treated with RP varied between 12.1% and 31.1%. In the French institution, RP was the most common treatment of prostate cancer (43.8% of patients). CONCLUSION: In China, most patients subjected to prostate biopsy suffer from urinary symptoms and have elevated PSA levels. The lack of mass screening for prostate cancer results in a high rate of advanced tumors with nodal involvement and/or metastases. RP is rarely performed in Chinese hospitals, and castration represents the usual treatment of prostate cancer.


Asunto(s)
Neoplasias de la Próstata/diagnóstico , Neoplasias de la Próstata/terapia , Anciano , China , Francia , Humanos , Masculino , Persona de Mediana Edad
16.
J Colloid Interface Sci ; 555: 294-303, 2019 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-31394316

RESUMEN

To solve the energy crisis problem, many efforts have been devoted to develop clean and sustainable alternatives to fossil fuels. Among varieties of pathways to obtain clean energy, electrochemical water splitting is a promising approach. Herein, we had successfully synthesized the NiCo2S4@porous nitrogen-doped carbon nanofibers (NiCo2S4@NCNF) nanocomposite via three successive steps consisted of in-situ oxidative polymerization, calcination, and solvothermal sulfuration reaction processes. The effect of controlled molar ratios to electrocatalytic performance was studied in detail. The optimized NiCo2S4@NCNF nanocomposite exhibits superior electrocatalytic activity for hydrogen evolution reaction with a small overpotential of 117 mV to drive a current density of 10 mA cm-2. More importantly, it exhibits similar electrocatalytic activity to the initial state even after successive cyclic voltammetry scan for 3000 cycles, indicating its excellent long-term stability. The superior electrochemical performance is attributed to the developed three-dimensional (3D) network nanostructure derived from bacterial cellulose nanofibers, the highly conductive porous nitrogen-doped carbon nanofibers, and the synergistic effect between metal Ni and Co of NiCo2S4. This study permits a new pathway to design efficient electrocatalysts based on eco-friendly materials for the production of clean hydrogen energy.

17.
Oncol Rep ; 19(1): 171-5, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18097592

RESUMEN

In the current study, we analysed the prognostic value of vascular endothelial growth factor receptor-1 (VEGFR-1) in clinically-localized prostate cancer (PCa). Forty patients who had undergone radical prostatectomy (RP) for clinically-localized PCa were included. Two groups were compared: 17 patients who experienced cancer progression following RP (group 1) and 23 patients who remained free of recurrence after intervention (group 2). Paraffin-embedded sections obtained from the RP specimens of the 40 patients were used to build tissue microarrays. The expression of VEGFR-1 was examined in the RP specimens using immunohistochemistry and was compared between the groups of patients. The two groups had similar tumor characteristics in terms of PSA, Gleason score and pathological stage of cancer. The median intensity score of VEGFR-1 expression was significantly higher in pT3 tumors than in pT2 tumors. Nevertheless, the intensity scores of VEGFR-1 expression were similar in the two groups of patients. Our results suggest that VEGFR-1 expression is not associated with the risk of cancer progression following RP. Therefore, VEGFR-1 may not be of prognostic value in clinically-localized PCa.


Asunto(s)
Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo , Anciano , Biomarcadores de Tumor/análisis , Progresión de la Enfermedad , Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Pronóstico , Prostatectomía , Neoplasias de la Próstata/cirugía , Factores de Riesgo , Análisis de Matrices Tisulares
18.
Can J Urol ; 15(5): 4257-62, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18814815

RESUMEN

OBJECTIVES: To study the prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor VEGFR-1 in localized prostate cancer. METHODS: One hundred patients undergoing radical prostatectomy (RP) for clinically localized prostate cancer were prospectively included. Plasma levels of VEGF-A were measured preoperatively. After intervention, tissue microarrays were built from the RP specimens. VEGF-A and VEGFR-1 expressions in prostate cancer tissue were determined using immunochemistry. Then the associations between plasma levels of VEGF-A, VEGF-A and VEGFR-1 expressions in prostate cancer tissue, and the outcome of patients were analyzed. RESULTS: After a median follow-up of 22 months, 14 patients experienced biological recurrence of prostate cancer. There was no correlation between plasma VEGF-A and the risk of recurrence following RP. Moreover, there was no correlation between VEGF-A expression or VEGFR-1 expression in prostate cancer tissue and the risk of recurrence after RP. CONCLUSIONS: Plasma levels of VEGF-A, the expression of VEGF-A and that of VEGFR-1 in prostate cancer tissue did not affect patients outcome following RP. VEGF-A and its receptor VEGFR-1 may have no prognostic value in localized prostate cancer. Further studies with longer follow-up are mandatory to confirm these findings.


Asunto(s)
Prostatectomía , Neoplasias de la Próstata/metabolismo , Receptores de Factores de Crecimiento Endotelial Vascular/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Adulto , Anciano , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Neoplasias de la Próstata/cirugía , Análisis por Matrices de Proteínas , Factor A de Crecimiento Endotelial Vascular/sangre , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo
19.
Oncol Rep ; 18(1): 145-9, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17549360

RESUMEN

Although the impact of vascular endothelial growth factor (VEGF) is clearly established in advanced prostate cancer (PCa), its role in localized PCa remains to be determined. The aim of our study was to analyse the plasma levels of VEGF-A and the expression of VEGF-A in prostatic tissue in a population of patients with localized PCa. We measured the preoperative plasma levels of VEGF-A in 100 patients undergoing radical prostatectomy (RP) for clinically-localized PCa. After intervention, we determined the expression of VEGF-A in all RP specimens using immunohistochemistry. We found no association between plasma levels of VEGF-A and the established prognostic factors of PCa. Moreover, there was no association between plasma levels of VEGF-A and the expression of VEGF-A in prostatic tissue. On the contrary, there was a strong correlation between the expression of VEGF-A in PCa tissue and the Gleason score of cancer: the expression of VEGF-A was significantly higher in patients with a high Gleason score on RP specimen (p=0.01). Our results suggest that the expression of VEGF may have a prognostic impact in clinically-localized PCa.


Asunto(s)
Biomarcadores de Tumor/sangre , Neoplasias de la Próstata/sangre , Factor A de Crecimiento Endotelial Vascular/sangre , Anciano , Biomarcadores de Tumor/metabolismo , Progresión de la Enfermedad , Ensayo de Inmunoadsorción Enzimática , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Pronóstico , Antígeno Prostático Específico , Prostatectomía , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/cirugía , Análisis de Matrices Tisulares , Factor A de Crecimiento Endotelial Vascular/metabolismo
20.
Mater Sci Eng C Mater Biol Appl ; 70(Pt 1): 763-771, 2017 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-27770953

RESUMEN

Monodispersed SPIONs (superparamagnetic iron oxide nanoparticles) co-coated with PEG and PEI polymers were prepared by an improved polyol method. To accomplish cancer-specific targeting properties, FA (folic acid) was then modified on the SPIONs via EDC/NHS method (FA-SPIONs). Doxorubicin (DOX) as an example anticancer drug was loaded within FA-SPIONs (DOX@FA-SPIONs), the DOX release rate of DOX@FA-SPIONs was much high in low pH PBS. The SPIONs, FA-SPIONs and DOX@FA-SPIONs with mean hydrodynamic diameters of 23, 40 and 67nm, respectively, performed excellent colloidal stability in PBS. Confocal laser scanning microscope (CLSM) study implicates that the DOX@FA-SPIONs target MCF-7 cells efficiently through the FA receptor-mediated endocytosis. DOX@FA-SPIONs were tested in nude mice with xenograft MCF-7 breast tumor though tail intravenous injection and were found inhibiting tumor growth more efficiently. The application of a magnetic field (MF) greatly improved the growth inhibiting efficiencies of DOX@FA-SPIONs on MCF-7 cells in vitro and on xenograft MCF-7 breast tumor of nude mice in vivo. The aggregation of SPIONs in tumor was monitored by magnetic resonance imaging (MRI) as the DOX@FA-SPIONs exhibited high r2 relaxivity (81.77mM-1S-1). Histology on liver, Lung, kidney and heart in mice showed no significant toxicity of DOX@FA-SPIONs on mice organs after 35-day treatment. The FA-SPIONs are a high efficient drug delivery nanoplatform for advanced cancer theranostics.


Asunto(s)
Dextranos/química , Sistemas de Liberación de Medicamentos , Ácido Fólico/química , Imagen por Resonancia Magnética , Nanopartículas de Magnetita/química , Nanopartículas/química , Neoplasias/diagnóstico , Neoplasias/terapia , Nanomedicina Teranóstica/métodos , Animales , Antineoplásicos/farmacología , Muerte Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Doxorrubicina/farmacología , Femenino , Humanos , Hidrodinámica , Concentración de Iones de Hidrógeno , Células MCF-7 , Ratones Endogámicos BALB C , Ratones Desnudos , Nanopartículas/ultraestructura , Tamaño de la Partícula , Propiedades de Superficie , Distribución Tisular/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA